aTyr Pharma (LIFE)

aTyr Pharma (LIFE) Financial Statements


aTyr Pharma Financial Overview

aTyr Pharma's market cap is currently ―. The company's EPS TTM is $-0.963; its P/E ratio is -1.96; aTyr Pharma is scheduled to report earnings on March 19, 2024, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 353.00K--$ 10.39M$ 0.00
Gross Profit$ 353.00K--$ 10.39M-
EBIT$ -11.34M$ -12.34M$ -11.95M$ -7.95M$ -13.49M
EBITDA-$ -12.64M$ -11.62M$ -7.32M$ -13.08M
Net Income Common Stockholders$ -11.34M$ -12.30M$ -11.95M$ -7.52M$ -13.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 102.13M$ 108.58M$ 114.39M$ 66.15M$ 77.37M
Total Assets$ 125.07M$ 132.73M$ 136.84M$ 95.79M$ 96.06M
Total Debt$ 15.22M$ 15.39M$ 14.29M$ 11.53M$ 8.65M
Net Debt$ -86.91M$ -93.19M$ -100.10M$ -54.61M$ -68.72M
Total Liabilities$ 26.87M$ 26.70M$ 27.14M$ 24.50M$ 19.05M
Stockholders Equity$ 98.39M$ 106.26M$ 109.88M$ 71.46M$ 77.18M
Cash Flow-
Free Cash Flow-$ -14.39M$ -1.84M$ -11.49M$ -12.71M
Operating Cash Flow$ -9.56M$ -12.01M$ -590.00K$ -10.37M$ -12.28M
Investing Cash Flow$ 4.38M$ -4.16M$ -38.17M$ 2.00M$ 20.65M
Financing Cash Flow$ 2.68M$ 8.02M$ 49.50M$ 918.00K$ 3.01M
Currency in USD

aTyr Pharma Earnings and Revenue History

aTyr Pharma Debt to Assets

aTyr Pharma Cash Flow

aTyr Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis